NCT03647072View on ClinicalTrials.gov

PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy

PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2027

Conditions
Lymphoma
Interventions
DRUG

CHOP

CHOP only

DRUG

CHOP Plus Lanzoprazole

CHOP plus Lanzoprazole 60 mg

DRUG

CHOP Plus Famotidine

CHOP Plus Famotidine 40 mg

Trial Locations (1)

Unknown

RECRUITING

Sherief Abd-Elsalam, Cairo

All Listed Sponsors
lead

Sherief Abd-Elsalam

OTHER